Skip to main content Accessibility help
×
Home

Does Extent of Resection Impact Survival in Patients Bearing Glioblastoma?

Published online by Cambridge University Press:  02 December 2014


Nicolas Dea
Affiliation:
Division of Neurosurgery and Neuro-oncology, Surgery Department, Université de Sherbrooke, Sherbrooke
Marie-Pierre Fournier-Gosselin
Affiliation:
Division of Neurosurgery, Surgery Department, Université de Montréal, Montréal, Quebec, Canada
David Mathieu
Affiliation:
Division of Neurosurgery and Neuro-oncology, Surgery Department, Université de Sherbrooke, Sherbrooke
Philippe Goffaux
Affiliation:
Division of Neurosurgery and Neuro-oncology, Surgery Department, Université de Sherbrooke, Sherbrooke
David Fortin
Affiliation:
Division of Neurosurgery and Neuro-oncology, Surgery Department, Université de Sherbrooke, Sherbrooke
Corresponding

Abstract

Background:

The impact of malignant glioma resection on survival is still a matter of controversy. The lack of well-designed prospective studies as well as control of all factors in retrospective studies plays an important role in this debate. Amongst some of these uncontrolled factors, are the inclusion of different histological grades, the lack of objective methods to estimate the extent of resection and unspecified delays in post-operative imaging.

Methods:

We retrospectively reviewed 126 consecutive patients with glioblastoma, operated on by the senior authors at the Centre Hospitalier Universitaire de Sherbrooke, who met the following criteria: >18 years of age, newly diagnosed glioblastoma, pre-operative magnetic resonance imaging (MRI) within 2 weeks prior to surgery, and a post-operative MRI within 72 hours after surgery. Extent of tumour resection was calculated using pre and post-operative tumour delimitation on gadolinium-enhanced T1 MRI in a volumetric analysis.

Results:

Applying stringent specific inclusion criteria, 126 patients were retained in the analysis. The median overall survival was 271 days and the median extent of resection was 65%. Patients with more than 90% of tumour resection had a significantly better outcome, improving median survival from 225 to 519 days (P=0.006). Other factors that significantly improved survival were the use of radiotherapy, the number of regimens and type of chemotherapy used.

Conclusion:

A more aggressive approach combining maximal safe resection and use of salvage chemotherapy seems to confer a survival advantage for glioblastoma patients.


Type
Original Articles
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Stupp, R, Mason, WP, van den Bent, MJ, et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:98796.CrossRefGoogle ScholarPubMed
2.Dandy, W.Physiological studies following extirpation of right cerebral hemisphere in man. Bull Johns Hopkins Hosp. 1933;33: 3151.Google Scholar
3.Hosli, P, Sappino, AP, de Tribolet, N, Dietrich, PY.Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann Oncol. 1998;9:589600.CrossRefGoogle ScholarPubMed
4.Mason, WP, Maestro, RD, Eisenstat, D, et al.Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol. 2007;14:11017.CrossRefGoogle ScholarPubMed
5.Sanai, N, Berger, MS.Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:75364.CrossRefGoogle Scholar
6.Hart, MG, Grant, R, Garside, R, Rogers, G, Somerville, M, Stein, K.Temozolomide for high grade glioma.Cochrane Database Syst. Rev. 2008;CD007415.Google Scholar
7.Hesson, LB, Krex, D, Latif, F.Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother. 2008;8:147596.CrossRefGoogle ScholarPubMed
8.Schneider, JP, Trantakis, C, Rubach, M, et al.Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme - a quantitative radiological analysis. Neuroradiology. 2005;47:489500.CrossRefGoogle ScholarPubMed
9.Lacroix, M, Abi-Said, D, Fourney, DR, et al.A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:1908.CrossRefGoogle Scholar
10.Albert, FK, Forsting, M, Sartor, K, Adams, HP, Kunze, S.Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumour and its influence on regrowth and prognosis. Neurosurgery. 1994;34:4560.Google ScholarPubMed
11.Henegar, MM, Moran, CJ, Silbergeld, DL.Early postoperative magnetic resonance imaging following nonneoplastic cortical resection. J Neurosurg. 1996;84:1749.CrossRefGoogle ScholarPubMed
12.Ekinci, G, Akpinar, IN, Baltacioglu, F, et al.Early-postoperative magnetic resonance imaging in glial tumours: prediction of tumour regrowth and recurrence. Eur J Radiol. 2003;45:99107.CrossRefGoogle ScholarPubMed
13.Keles, GE, Anderson, B, Berger, MS.The effect of extent of resection on time to tumour progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol. 1999;52:3719.CrossRefGoogle ScholarPubMed
14.Keles, GE, Chang, EF, Lamborn, KR, et al.Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg. 2006;105:3440.CrossRefGoogle ScholarPubMed
15.Pope, WB, Sayre, J, Perlina, A, Villablanca, JP, Mischel, PS, Cloughesy, TF.MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005;26:246674.Google Scholar
16.McGirt, MJ, Chaichana, KL, Gathinji, M, et al.Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110:15662.CrossRefGoogle ScholarPubMed
17.Gutin, PH, Posner, JB.Neuro-oncology: diagnosis and management of cerebral gliomas-past, present, and future. Neurosurgery. 2000;47:18.Google ScholarPubMed
18.Fortin, D.Altering the properties of the blood-brain barrier: disruption and permeabilization. Prog Drug Res. 2003;61:12554.Google ScholarPubMed
19.Fortin, D, Desjardins, A, Benko, A, Niyonsega, T, Boudrias, M.Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumours: the Sherbrooke experience. Cancer. 2005;103:260615.CrossRefGoogle ScholarPubMed
20.Walker, MD.The contemporary role of chemotherapy in the treatment of malignant brain tumour. Clin Neurosurg. 1978;25:38896.Google Scholar

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 111 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 1st December 2020. This data will be updated every 24 hours.

Access
Hostname: page-component-79f79cbf67-2v79d Total loading time: 1.415 Render date: 2020-12-01T21:28:04.026Z Query parameters: { "hasAccess": "1", "openAccess": "0", "isLogged": "0", "lang": "en" } Feature Flags last update: Tue Dec 01 2020 21:05:22 GMT+0000 (Coordinated Universal Time) Feature Flags: { "metrics": true, "metricsAbstractViews": false, "peerReview": true, "crossMark": true, "comments": true, "relatedCommentaries": true, "subject": true, "clr": false, "languageSwitch": true }

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Does Extent of Resection Impact Survival in Patients Bearing Glioblastoma?
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Does Extent of Resection Impact Survival in Patients Bearing Glioblastoma?
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Does Extent of Resection Impact Survival in Patients Bearing Glioblastoma?
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *